Clinical Trial Update: Study of TAK-935 as an Adjunctive Therapy in Adult Participants With Complex Regional Pain Syndrome (CRPS) [Phase 2]

View source ↗

Summary

A Phase 2 study of TAK-935 as an adjunctive therapy for adult Complex Regional Pain Syndrome has completed, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome

Drugs mentioned

• TAK-935

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Complex Regional Pain Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2021-07-15